"Despite the potential for adverse maternal and fetal outcomes, contraceptive use in women with certain medical conditions is suboptimal, according to a new study.
Steven W. Champaloux, PhD, MPH, a scientist in the Division of Reproduc"...
Serious ill effects have not been reported following acute ingestion of large doses of oral contraceptives by young children. Overdosage may cause nausea, and withdrawal bleeding may occur in females.
Noncontraceptive Health Benefits
The following noncontraceptive health benefits related to the use of oral contraceptives are supported by epidemiological studies which largely utilized oral contraceptive formulations containing doses exceeding 0.035 mg of ethinyl estradiol or 0.05 mg of mestranol.
Effects on menses
Increased menstrual cycle regularity.
Decreased blood loss and decreased incidence of iron-deficiency anemia.
Decreased incidence of dysmenorrhea.
Effects related to inhibition of ovulation
Decreased incidence of functional ovarian cysts.
Decreased incidence of ectopic pregnancies.
Effects from long-term use
Decreased incidence of fibroadenomas and fibrocystic disease of the breast.
Decreased incidence of acute pelvic inflammatory disease.
Decreased incidence of endometrial cancer.
Decreased incidence of ovarian cancer.
Combination oral contraceptives should not be used in women with any of the following conditions:
A past history of deep-vein thrombophlebitis or thromboembolic disorders.
Cerebral-vascular or coronary artery disease.
Thrombogenic rhythm disorders.
Diabetes with vascular involvement.
Known or suspected carcinoma of the breast.
Carcinoma of the endometrium or other known or suspected estrogen-dependent neoplasia.
Undiagnosed abnormal genital bleeding.
Cholestatic jaundice of pregnancy or jaundice with prior pill use.
Hepatic adenomas or carcinomas, or active liver disease, as long as liver function has not returned to normal.
Known or suspected pregnancy.
Hypersensitivity to any of the components of Nordette®-28 (levonorgestrel and ethinyl estradiol tablets).
Last reviewed on RxList: 8/23/2013
Additional Nordette-28 Information
Report Problems to the Food and Drug Administration
Find out what women really need.